APRV/BIPAP With Spontaneous Breathing on Lung Protection
APRV/BIPAP
Impact of the Type of Pressure Controlled Mode on Lung Protection in Mechanically Ventilated Patients With Spontaneous Breathing
1 other identifier
interventional
15
1 country
2
Brief Summary
Mechanical ventilation (MV) is a cornerstone of management of acute respiratory failure, but MV per se can provoke ventilator-induced lung injury (VILI), especially in acute respiratory distress syndrome (ARDS). Lung protective ventilation strategy has been proved to prevent VILI by using low tidal volume of 6-8 ml/kg of ideal body weight and limiting plateau pressure to less than 30 cmH2O. However, heavy sedation or even paralysis are frequently used to ensure the protective ventilation strategy, both of which are associated with respiratory muscles weakness. Maintaining of spontaneous breathing may decrease the need of sedative drug and improve gas exchange by promoting lung recruitment. Pressure-targeted mode is the most frequent way of delivering after 48 hours of initiating MV. Three types of pressure-controlled mode are available in intubated patients: Biphasic Intermittent Positive Airway Pressure (BIPAP), Airway Pressure Release Ventilation (APRV), and Pressure-Assist Controlled Ventilation (also called BIPAPassist). They are based on pressure regulation but have the difference in terms of synchronization between the patient and the ventilator. The different working principle of these modes may result in different breathing pattern and consequently different in tidal volume and transpulmonary pressure, which may be potentially harmful. The investigators bench study with a lung model demonstrated higher tidal volume and transpulmonary pressure with the BIPAPassist over APRV despite similar pressure settings and patient's simulated effort. However, the impact of each mode on the delivered tidal volume and the transpulmonary pressure in spontaneously breathing mechanically ventilated patients is currently unknown. Their hypothesis is that when the investigators compare the three pressure-controlled modes, the asynchronous mode (APRV) will result in more protective ventilation strategy over the two other modes (BIPAP and BIPAPassist).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2014
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2014
CompletedFirst Posted
Study publicly available on registry
February 25, 2014
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2017
CompletedApril 19, 2017
April 1, 2017
2.8 years
February 7, 2014
April 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tidal volume in each mode of ventilation
20 minutes
Secondary Outcomes (3)
Inspiratory transpulmonary pressure in each mode of ventilation
20 minutes
Patient work of breathing
20 minutes
The frequency of each breath-type according to the mode
20 minutes
Study Arms (1)
Pressure targeted modes
EXPERIMENTALInterventions
Intervention involving three different pressure-targeted modes (APRV, BIPAP, and BIPAPassist) each in a random order generated by a computer on one ventilator. Each mode will be studied for 20 minutes.
Eligibility Criteria
You may qualify if:
- Male or female patient,
- Age over 18 years,
- Patient already ventilated with assist controlled mode (volume or pressure) and patient triggering the ventilator,
- Arterial line indwelling or planning to insert this line,
- Written informed consent signed and dated by the patient/next of kin after full explanation of the study by the study team and prior to study participation,
- Patient consent will be requested as soon as the patient will be able to provide informed written consent
You may not qualify if:
- Hemodynamic instability
- \> 20% variation of mean arterial pressure and/or heart rate (HR) in the last 2 hours,
- Need for high dose of vasopressor (higher than 0.2 mcg/kg/min of levophed),
- High PEEP (\> 12 cmH2O) and/or high fraction of inspired oxygen inspired oxygen fraction (\> 0.6)
- Severe acidosis (pH ≤ 7.20), or severe alkalosis (pH \> 7.55)
- Presence of a known esophageal problem, active upper gastrointestinal bleeding or any other contraindication to the insertion of a oro- or naso-gastric tube,
- Pregnant patient,
- Presence of intracranial hypertension,
- Known chronic neuromuscular disease significantly impairing the spontaneous breathing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unity Health Torontolead
- University of Torontocollaborator
Study Sites (2)
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
Mount Sinai Hospital
Toronto, Ontario, M5G1X5, Canada
Related Publications (2)
Richard JC, Lyazidi A, Akoumianaki E, Mortaza S, Cordioli RL, Lefebvre JC, Rey N, Piquilloud L, Sferrazza Papa GF, Mercat A, Brochard L. Potentially harmful effects of inspiratory synchronization during pressure preset ventilation. Intensive Care Med. 2013 Nov;39(11):2003-10. doi: 10.1007/s00134-013-3032-7. Epub 2013 Aug 9.
PMID: 23928898BACKGROUNDRittayamai N, Beloncle F, Goligher EC, Chen L, Mancebo J, Richard JM, Brochard L. Effect of inspiratory synchronization during pressure-controlled ventilation on lung distension and inspiratory effort. Ann Intensive Care. 2017 Oct 6;7(1):100. doi: 10.1186/s13613-017-0324-z.
PMID: 28986852DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurent Brochard, Dr.
Unity Health Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2014
First Posted
February 25, 2014
Study Start
March 1, 2014
Primary Completion
January 1, 2017
Study Completion
March 15, 2017
Last Updated
April 19, 2017
Record last verified: 2017-04